Acyl ghrelin infusion increases circulating growth hormone in patients with heart failure and reduced ejection fraction.

Supporting Information Supplementary Figure 1. Associations between baseline characteristics and below (left) and above (right) median of the AUC growth hormone. (BMI= Body Mass Index; EF =Ejection Fraction; eGFR=estimated Glomerular Filtration Rate; HF=Heart Failure; HOMA-IR= Homeostatic Model Assessment of Insulin Resistance; LV= Left Ventricular, NT-proBNP= N-terminal prohormone of brain natriuretic peptide) Statistical analyses were performed using SAS software version 9.3 (SAS Institute, Cary, North Carolina). Supplementary Table 1. Baseline characteristics in HFrEF patients receiving acyl ghrelin presented in GH high responders compared to GH low responders. Continuous variables are presented as median and lower and upper quartiles (Q1;Q3) and categorical variables as numbers (n) and percentages (%). Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.